Royal London Asset Management Ltd. Has $22.02 Million Stock Position in Astera Labs, Inc. $ALAB

Royal London Asset Management Ltd. boosted its position in Astera Labs, Inc. (NASDAQ:ALAB) by 8.7% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 45,588 shares of the company’s stock after acquiring an additional 3,659 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Astera Labs were worth $22,020,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently bought and sold shares of ALAB. Van ECK Associates Corp lifted its position in Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after acquiring an additional 373,545 shares during the last quarter. Nissay Asset Management Corp Japan lifted its position in shares of Astera Labs by 79.6% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 105,965 shares of the company’s stock worth $51,183,000 after purchasing an additional 46,952 shares during the last quarter. Wellington Management Group LLP boosted its stake in Astera Labs by 151.5% during the 2nd quarter. Wellington Management Group LLP now owns 248,914 shares of the company’s stock valued at $120,230,000 after purchasing an additional 149,951 shares during the period. Archer Investment Corp acquired a new stake in Astera Labs in the 2nd quarter valued at approximately $30,000. Finally, Kingsview Wealth Management LLC bought a new position in Astera Labs in the 2nd quarter worth approximately $2,553,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $289.47 on Monday. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a market capitalization of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84. The business’s 50-day simple moving average is $342.38 and its 200-day simple moving average is $250.08.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Analyst Upgrades and Downgrades

ALAB has been the subject of several research reports. Evercore reissued an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. TD Cowen cut their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Finally, Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $340.53.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 419,244 shares of company stock valued at $163,135,169 over the last three months. Insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.